Baird Medical Leads Global Dialogue on Microwave Ablation in Beijing

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) has solidified its position as a leader in minimally invasive Microwave Ablation (MWA) technology by participating in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. This significant event took place at the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025.

Baird Medical’s involvement in this workshop underscores its commitment to advancing global collaboration in the field of thyroid treatment. The event gathered leading experts and clinicians from around the world to discuss the latest advancements in thermal ablation techniques. This innovative technology has shown promise in treating thyroid tumors and conditions related to hyperparathyroidism, offering patients a less invasive option for care.

During the workshop, participants engaged in a series of presentations and discussions focused on MWA methodologies, patient outcomes, and future research directions. The forum facilitated knowledge exchange among healthcare professionals, aiming to enhance treatment protocols and improve patient care standards worldwide.

Baird Medical’s representatives shared insights on their latest findings and technological advancements in MWA, highlighting the benefits of this approach in reducing recovery times and minimizing complications compared to traditional surgical methods. The company aims to further establish partnerships within the medical community to expand the use of MWA globally.

As the demand for minimally invasive procedures grows, Baird Medical is poised to play a crucial role in shaping the future of thyroid treatment. The company’s participation in significant international conferences like this one demonstrates its dedication to innovation and collaboration in healthcare.

The workshop not only served as a platform for knowledge sharing but also reinforced the importance of ongoing education and professional development in the medical field. Experts emphasized the need for continuous research and clinical trials to validate the effectiveness of new techniques and improve patient outcomes.

Baird Medical’s active involvement in such discussions reflects its broader mission to enhance healthcare delivery through cutting-edge technology. As the global healthcare landscape evolves, the company remains committed to investing in research and development, ensuring that patients have access to advanced treatment options.

In conclusion, the 3rd International Workshop on Thermal Ablation marked a significant milestone for Baird Medical and the broader medical community. With a focus on collaboration, education, and innovation, the event highlighted the potential of Microwave Ablation technology in transforming the treatment of thyroid-related conditions. Baird Medical is determined to continue leading the way in this vital area of healthcare.